Abstract: |
Prostate cancer is the most common solid tumor in men. There are several treatment options for men diagnosed with clinically localized prostate cancer. There is an obvious need for decision-making tools that individual patients can apply to the specific parameters of their disease to reach an informed decision. In order to make accurate and informed decisions about treatment choices for prostate cancer, the patient and clinician must follow an orderly decision-making process. The most important starting point for decision analysis is to review the available literature for each treatment modality and elucidate the respective success rates in cancer control, including prostate specific antigen (PSA) recurrence, local and distant recurrence, and cancer-specific survival, and ascertain significant predictors of treatment success or failure. The decision-making process for prostate cancer is not straightforward. There are multiple treatment modalities with similar cancer control, especially for low-risk patients. Fortunately, the field of decision analysis and outcomes research is expanding rapidly and will improve the decision-making process in the years to come. © 2003 Elsevier Ltd. All rights reserved. |